Patents Represented by Attorney, Agent or Law Firm Michael U. Lee
-
Patent number: 7517844Abstract: A composition comprising a mixing product of: (i) a first acid having a pKa of less than 3, in an amount by weight of 1-10%, (ii) a second acid having a pKa of greater than 3, in an amount by weight of 1-10%, (iii) a nonionic surfactant in an amount by weight of 1-7%; and (iv) water; wherein the composition has a pH of less than 2.5. The composition can be used for the removal of grease, lime scale, soap scum, and rust on hard surfaces.Type: GrantFiled: June 4, 2008Date of Patent: April 14, 2009Assignee: Colgate-Palmolive CompanyInventors: Patrick Diet, Jean Massaux, Isabelle Leonard
-
Patent number: 7470653Abstract: A light duty liquid cleaning composition comprising at least one ammonium or metal salt of a C8-C16 linear alkyl benzene sulfonate surfactant, at least one ammonium or metal salt of an ethoxylated C8-C18 alkyl ether sulfate surfactant having 1 to 30 moles of ethylene oxide, and at least one betaine surfactant; wherein (a) a total amount of surfactant in the composition is at least 30 weight %, (b) the composition has a pH less than 7 and a viscosity of less than 75 cPs measured at 25° C., (c) if a magnesium salt of a C8-C16 linear alkyl benzene sulfonate surfactant is present in the composition, it is present in an amount of 0.1 to less than 3 or greater than 16% by weight of the composition, and (d) the composition does not contain an inorganic magnesium salt.Type: GrantFiled: April 7, 2006Date of Patent: December 30, 2008Assignee: Colgate-Palmolive CompanyInventors: Joan Ethel Gambogi, Cynthia McCullar Murphy, David Frank Suriano
-
Patent number: 7449436Abstract: A light duty liquid cleaning composition comprising at least one ammonium or metal salt of a C8-C16 linear alkyl benzene sulfonate surfactant, at least one ammonium or metal salt of an ethoxylated C8-C18 alkyl ether sulfate surfactant having 1 to 30 moles of ethylene oxide, and at least one betaine surfactant; wherein (a) a total amount of surfactant in the composition is at least 30 weight %, (b) the composition has a pH less than 7 and a viscosity of less than 75 cPs measured at 25° C. (c) if a magnesium salt of a C8-C16 linear alkyl benzene sulfonate surfactant is present in the composition, it is present in an amount of 0.Type: GrantFiled: October 8, 2007Date of Patent: November 11, 2008Assignee: Colgate-Palmolive CompanyInventors: Joan Ethel Gambogi, Cynthia McCullar Murphy, David Frank Suriano
-
Patent number: 6759407Abstract: Novel pesticides of formula (I) wherein the substituents, R, R1, R2, R2′, T, U, X and Y are as defined in claim 1, are described. Also described are compositions suitable for use as parasiticides comprising those compounds as active ingredient and to methods of controlling parasites that are based on the administration of those compounds or compositions, and to the use of the said compounds and compositions in a method of controlling parasites and in the manufacture of pesticides for use against parasites. Also described are intermediates of formula (XX) wherein R1, R2, R2′, T, U, X and Y are as defined in claim 1; and Hal is halogen. The latter also exhibit parasiticidal activity and are suitable for the preparation of the compounds of formula (I).Type: GrantFiled: January 21, 2003Date of Patent: July 6, 2004Assignee: Novartis Animal Health US, Inc.Inventors: Thomas Goebel, Eliane Humbert-Droz, Maurizio Schwarzenbach
-
Patent number: 6713305Abstract: There are provided membrane-associated polypeptides having the sequence shown in SEQ ID Nos. 1 and 9. Also provided are immunogenic determinants derived from said polypeptides and antibodies raised thereto. The polypeptides, their derived antigenic determinants and the antibodies are useful for the diagnosis and treatment of metastatic potential in tumors.Type: GrantFiled: October 23, 1998Date of Patent: March 30, 2004Assignee: Novartis AGInventors: Felix Bachmann, Max M. Burger
-
Patent number: 6686469Abstract: The invention relates to compounds of the general formula wherein R1 is unsubstituted or mono- to penta-substituted aryl, whereby the substituents are selected from the group consisting for instance of OH, Halogen, CN, C1-C6-alkyl, optionally substituted C3-C8-cycloalkyl and optionally substituted C3-C8-cycloalkenyl; A is for instance a single bond, C1-C12-alkylene or O; X1 and X2, independently of one another, are R10; X3 is H or R10; R10 is for instance halogen, CN, NO2, C1-C6-alkyl, C3-C8-cycloalkyl or C1-C6-haloalkyl; R21 and R22, independently of one another are for instance H, halogen, CN, NO2, OH, SH, C1-C6-alkyl, C3-C8-cycloalkyl, C1-C6-alkyl-C3-C8-cycloalkyl or C3-C8-cycloalkyl-C1-C6-alkyl; R23 and R24, independently of one another, are for instance H, C1-C6-alkyl, C3-C8-cycloalkyl, C3-C8-cycloalkyl-C1-C6-alkyl, C1-C6-haloalkyl or C3-C8-halocycloalkyl; m is 1, 2, 3 or 4; and n is 0, 1 or 2; as well as the physiologically acceptable addition compounds, a method of producingType: GrantFiled: November 5, 2001Date of Patent: February 3, 2004Assignee: Novartis Animal Health US, Inc.Inventors: Martin Eberle, André Jeanguenat, Werner Zambach, Arthur Steiger, Saleem Farooq
-
Patent number: 6673820Abstract: The invention relates to novel compounds of the general formula: in which R1 is hydrogen, halogen, C1-C6alkyl, C1-C6alkoxy, C1-C6haloalkyl or unsubstituted or mono- to pentasubstituted phenyl, where the substituents are selected from the group consisting of C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, aryloxy, halogen, cyano and nitro, where, if the number of substituents exceeds 1, the substituents can be identical or different; R2 is hydrogen, C1-C6alkyl, (C1-C6alkylene)phenyl, pyridyl, COOR6, CONR7R8, COR6, allyl or CH2—O—R6; R3 is unsubstituted or substituted heterocyclyl, where the substituents are in each case selected from the group consisting of unsubstituted or substituted phenyl, where the substituents are selected from the group consisting of C1-C6alkyl, C1-C6alkoxy, halogen, cyano and nitro, where, if the number of substituents exceeds 1, the substituents can be identical or different, benzyl, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxy, aryloxy, halogen, cyano, hydroxyl, amiType: GrantFiled: May 31, 2002Date of Patent: January 6, 2004Assignee: Novartis Animal Health US, Inc.Inventors: Pierre Ducray, Jacques Bouvier, Maurizio Schwarzenbach
-
Patent number: 6667326Abstract: The invention relates to compounds of the general formula wherein R1, R2, R3, R4, R5, X1, X2, X3, m and n have the significances given in claim 1, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for the control of pests on domestic and farm animals.Type: GrantFiled: May 16, 2002Date of Patent: December 23, 2003Assignee: Novartis Animal Health US, Inc.Inventors: Pierre Ducray, Jacques Bouvier, Urs Müller
-
Patent number: 6627203Abstract: The invention provides an immune stimulating agent or vaccine directed to Renibacterium salmoninarum comprising a live non-virulent culture of an Arthrobacter strain based on, derived from or substantially homologous with strain RSxII as deposited as ATCC 55921. The culture may be presented in lyophilized form with a sterile diluent.Type: GrantFiled: April 5, 2000Date of Patent: September 30, 2003Assignee: Aqua Health (Europe) LimitedInventors: Steven Gareth Griffiths, Kira Salonius
-
Patent number: 6620767Abstract: The invention relates to compounds of the general formula wherein R1 is hydrogen, halogen, C1-C6-alkyl, C1-C6-alkoxy, C1-C6-haloalkyl or unsubstituted or mono- to penta-substituted phenyl, whereby the substituents are selected from the group comprising C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, aryloxy, halogen, cyano and nitro, whereby if the number of substituents is greater than 1, the substituents may be identical or different; R2 is hydrogen, C1-C6-alkyl, (C1-C6-alkylene)phenyl, pyridyl, COOR6, CONR7R8COR6, allyl or CH2—O—R6; R3 is C1-C6-alkyl; R4 is unsubstituted or substituted phenyl, unsubstituted or substituted benzyl or unsubstituted or substituted heterocyclyl, whereby each of the substituents, independently of each other, is selected from the group comprising C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, aryloxy, halogen, cyano, hydroxy, amino and nitro, whereby if the number of substituents is greater than 1, the substituents may be identical or different; R6 is C1-C6Type: GrantFiled: May 28, 2002Date of Patent: September 16, 2003Assignee: Novartis Animal Health US, Inc.Inventors: Pierre Ducray, Jacques Bouvier
-
Patent number: 6538031Abstract: A method of successfully controlling sea lice in commercial fish farming, in an efficient and environmentally friendly way, with the compounds named in claim 1, preferably by injection, and a method of automating this type of control, are described.Type: GrantFiled: November 20, 2000Date of Patent: March 25, 2003Assignee: Novartis Animal Health US, Inc.Inventor: Hariolf Schmid
-
Patent number: 6538013Abstract: Novel pesticides of formula (I) wherein the substituents R, R1, R2, R2′, T, U, X and Y are as defined in claim 1, are described. Also described are compositions suitable for use as parasiticides comprising those compounds as active ingredient and to methods of controlling parasites that are based on the administration of those compounds or compositions, and to the use of the said compounds and compositions in a method of controlling parasites and in the manufacture of pesticides for use against parasites. Also described are intermediates of formula (XX) wherein R1, R2, R2′, T, U, X and Y are as defined in claim 1 and Hal is halogen. The latter also exhibit parasiticidal activity and are suitable for the preparation of the compounds of formula (I).Type: GrantFiled: May 7, 2001Date of Patent: March 25, 2003Assignee: Novartis Animal Health US, Inc.Inventors: Thomas Goebel, Eliane Humbert-Droz, Maurizio Schwarzenbach
-
Patent number: 6471981Abstract: The present invention comprises a novel nutritional dietary composition that can be formulated for oral and enteral administration. The formulation derives substantially all of its protein from soy protein isolate or, in a second embodiment, from soy protein isolate and soy protein concentrate. If desirable, up to 10.0 wt. % of the soy protein component can be replaced with caseinates, free amino acids and mixtures thereof. A carbohydrate such as corn syrup, a gum such as carrageenan gum, a non-reactive magnesium source and optionally, dietary soy protein concentrate as well as various vitamins and other excipients may also make-up the rest of the formulation. The high soy composition provides an inexpensive and high nutritional quality source of protein.Type: GrantFiled: March 27, 2001Date of Patent: October 29, 2002Assignee: Novartis Nutrition AGInventor: Douglas Earl Hahn
-
Patent number: 6469067Abstract: An active ingredient combination for the simultaneous control of ecto- and endoparasites, especially mites, ticks and nematodes, on productive livestock, domestic animals and pets, is described, which comprises the active ingredients (1) 1-[4-chloro-3-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl]-3-(2,6-difluorobenzoyl)urea and (2) a compound of formula (i) wherein R1 is hydrogen or one of radicals R2 is —CH(CH3)—CH3, —CH(CH3)—C2H5, —C(CH3)═CH—CH(CH3)2 or cyclohexyl; R3 is hydrogen or hydroxy if the bond between atoms 22 and 23 represents a double bond, or is hydrogen or the group ═N—O—CH3 if a single bond is present between atoms 22 and 23; and R4 is HO— or HO—N═, in free form or in the form of a physiologically acceptable salt.Type: GrantFiled: November 20, 2000Date of Patent: October 22, 2002Assignee: Novartis AGInventors: Jacques Bouvier, Catherine Kolly
-
Patent number: 6458826Abstract: The invention describes essentially a non-therapeutical process for deterring vermin, which is based on the usage of the largely known compounds of formula (I), as defined herein before. Furthermore, it describes the corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of the formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defence against vermin. Thus, the invention describes how and in which form the compounds of the formula (I) or their acid addition salts are used to deter vermin from materials, places or warm-blooded animals.Type: GrantFiled: December 15, 2000Date of Patent: October 1, 2002Assignee: Navartis Animal Health US, Inc.Inventors: Olivier Froelich, Jacques Bouvier, Catherine Christinaz, Nicola Di Criscio
-
Patent number: 6419977Abstract: A novel meat extender composition for boosting the nutritional value of meat contains a four component dry mix system of whey protein concentrate, maltodextrin, a starch and non-fat dry milk. Additional vitamins, minerals, spices and a flavor enhancer may also be added to improve the organoleptic characteristics of the meat which is preferably ground or chopped for easier consumption.Type: GrantFiled: March 27, 2000Date of Patent: July 16, 2002Assignee: Novartis Nutrition AGInventor: Terri Alice Born
-
Patent number: 6410578Abstract: The present invention discloses a method for repelling insects, mites and ticks from warm-blooded animals with a benzazole compound.Type: GrantFiled: October 27, 2000Date of Patent: June 25, 2002Assignee: Novartis Animal Health US, Inc.Inventors: Jacques Bouvier, Catherine Christinaz, Olivier Froelich
-
Patent number: 6376544Abstract: L-arginine found essential to enhance the glomerular function of the kidneys is used &phgr; formulate a low viscosity, calorie-dense, nutritional product for a person having renal failure. In a product free of citric acid or citrates, for oral ingestion, the taste of arginine is counteracted by lactic, malic or adipic acid; in a formulation for tube-feeding, citric acid and citrates in a specified ratio controls the product's stability. The ratio of calcium to phosphorus is controlled, as is the caloric distribution and water content; the amounts of vitamins and minerals included provide a nutritionally complete formulation.Type: GrantFiled: February 2, 2001Date of Patent: April 23, 2002Assignee: Novartis Nutrition AGInventors: Carol Jo Lowry, Kathy Marie Sass
-
Patent number: 6332877Abstract: A catheter or ostomy tube placement tip is comprised of a tapered, substantially conical head portion and a cylindrical body or stem portion centrally attached to the base thereof. The cylindrical base fits snugly within the lumen of a catheter or ostomy tube such as a ostomy or jejunal feeding tube and its tapered design allows for the insertion and placement of the tube within the lumen of the stomach or other body cavity through an opening or ostomy. Once properly placed, the tip is discharged from the end of the tube so that it is dissolved by human body fluids and is excreted.Type: GrantFiled: May 12, 1998Date of Patent: December 25, 2001Assignee: Novartis AGInventor: Lester D. Michels
-
Patent number: D451806Type: GrantFiled: October 14, 1999Date of Patent: December 11, 2001Assignee: Novartis Nutrition AGInventor: Thomas Stalder